Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes

Clinica Chimica Acta

Volumn 303, Issue 1-2, 2001, Pages 167-179

  Möckel, Martin ^a   Gerhardt, Willie ^b   Heller Jr , Günther ^c   Klefisch, Frank ^a   Danne, Oliver ^a   Maske, Jakob ^a   Müller, Christian ^a   Störk, Thomas ^d   Frei, Ulrich ^a   Wu, Alan H B ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Department of Clinical Chemistry ^*  (Sweden)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d OLGAHOSPITAL   (Germany)

^e HARTFORD HOSPITAL   (United States)

Author keywords

Acute coronary syndrome; Diagnosis; Myoglobin; NACB and IFCC guidelines; Prognosis; Troponin I

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; GUIDELINES; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGLOBIN; PROSPECTIVE STUDIES; RISK ASSESSMENT; TROPONIN I;

EID: 0035146704     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00396-X     Document Type: Article

References (42)

1. Usefulness of serial determinations of myoglobin and creatine kinase in serum compared for assessment of acute myocardial infarction
2. Myoglobinemia in the early phase of acute myocardial infarction
3. Early diagnosis of acute myocardial infarction: CK-MB and myoglobin compared
4. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring
5. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin
6. Early detection of acute myocardial infarction: Additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation
7. Laboratory-based diagnosis of acute coronary syndromes: Results of the NOWIS pilot study
8. Myoglobin for diagnosis of infarction and reperfusion under clinical conditions
9. Analytical and clinical evaluation of creatine kinase MB mass assay by Imx: Comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction
10. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
11. Troponin T and myoglobin at admission: Value of early diagnosis of acute myocardial infarction
12. Failure of new biochemical markers to exclude acute myocardial infarction at admission
13. Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin T
14. Cardiac troponins: IT upgrade for the heart
15. Troponin T and CK MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg study, 1992
16. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB
17. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
18. Diagnostic efficiency of troponin T measurements in acute myocardial infarction
19. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease
20. Cardiac troponin T in diagnosis of acute myocardial infarction
21. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
22. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction
23. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction
24. The prognostic value of serum troponin T in unstable angina. Letter to the editor
25. The prognostic value of serum troponin T in unstable angina
26. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
27. Detection of myocardial damage by serial measurements of cardiac troponin T. CK-MB mass, and TropT rapid test
28. Standards of laboratory practice: Recommendations for use of cardiac markers in coronary artery disease
29. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes
30. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
31. Unstable angina: A classification
32. Troponin T: A sensitive and specific diagnostic and prognostic marker of myocardial damage
33. Cardiac troponin I. A marker with high specificity for cardiac injury
34. The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes
35. Can Troponin T replace CK-MB mass as 'gold standard' for acute myocardial infarction ('AMI')?
36. Risk stratification after myocardial infarction
37. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
38. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes
39. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: 9-months outcomes analysis
40. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I
41. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T
42. Myocardial infarction redefined - A consensus document of the Joint Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction